Aggregation in the pharmaceutical industry Aggregation can be part of the serialization solution on production lines. Serialization involves adding a unique identifier to each product at the individual package level, that is, at the level that patients or customers receive the product. However, those individual products do not arrive from the production line to the patient or customer through the distribution chain as an individual product at the package level. Instead, multiple products are packed at the individual pack level into boxes and then multiple boxes are packed onto pallets. The pharmaceutical industry has long used tertiary packaging (package, box, pallet) to facilitate supply chain operations. This process provides easy access to serial numbers for all packages within tertiary packaging when establishing parent-child relationships. In this way, the serial number of the package and the drugs can be accessed without opening any tertiary packaging. Drug serial numbers can be found through the SSCC code without opening the box at any point in the supply chain. Pharmaceutical aggregation establishes a relationship between the SSCC of tertiary packages and the serial number of all drugs and packages in the pharmaceutical production process. Traceability can be defined as tracking the points of a product throughout the supply chain with an electronic record system. This electronic registration system is usually given by what is established in the legislation, so that all manufacturers follow certain instructions when serializing their products and enter the traceability records of all the parties involved.
You might also like
For over 20 years, HEXA Ingenieros has helped companies around the world realize their performance goals with unique, custom-tailored automated solutions. In the wake of our expansion to St. Louis, Missouri, in 2017, we’re proud to announce that we’ve only grown from strength to strength.